glp-1 receptor agonists in pediatric and adolescent obesity diabetes: a systematic review of efficacy, metabolic effects, and safety Oral GLP-1-Based Therapeutics in the

Ruan Y, Jiang S, Gericke A

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial

Seino, Y

Notably, although gallbladder disorders frequently manifest, advanced gastrointestinal complications such as intestinal obstruction and periprocedural aspiration, and emergent concerns regarding suicidality and ocular problems require further longitudinal studies to refine the usage guidelines for GLP-1 RAs in susceptible populations